Trima Accel® 81002
Trima Accel 81002 is an apheresis system (FDA Class II; FDA product code GKT, Separator, automated, blood cell, diagnostic) made by Terumo BCT, Inc., listed under FDA premarket submission BK150269 (1 earlier submission) and listed in FDA GUDID since 15 Sep 2016 (UDI-DI 05020583810020), active as of 8 Nov 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
510(k) BK150269
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number05020583810020 | Date15 Sep 2016 | StatusListed |
| United States | FDA 510(k) | NumberBK150269 | Date— | StatusActive |
Official records
- AccessGUDID record 05020583810020
From the FDA record
- Device description
- Automated Blood Collection System
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA premarket submission BK150269 Active
- FDA GUDID UDI-DI 05020583810020 listed 15 Sep 2016 Listed
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Trima Accel®
- Generic name
- Apheresis system
- Model / reference
- 81002
- Primary DI / UDI-DI
- 05020583810020
- FDA product code
- GKT
- GMDN term
- Apheresis system
- Device class
- Class II
- Regulation number
- 864.9245
- GUDID distribution status
- In Commercial Distribution
Similar devices in this category
Other devices filed under Apheresis system.